1.Lowy FD. Staphylococcus aureus infections. New England Journal of Medicine 1998; 339: 520–532.
2.Harbarth S. Control of endemic methicillin-resistant Staphylococcus aureus – recent advances and future challenges. Clinical Microbiology and Infection 2006; 12: 1154–1162.
3.Marschall J, Mühlemann K. Duration of methicillin-resistant Staphylococcus aureus carriage, according to risk factors for acquisition. Infection Control and Hospital Epidemiology 2006; 27: 1206–1212.
4.Scanvic A, et al. Duration of colonization by methicillin-resistant Staphylococcus aureus after hospital discharge and risk factors for prolonged carriage. Clinical Infectious Disease 2001; 32: 1393–1398.
5.Robicsek A, Beaumont JL, Peterson LR. Duration of colonization with methicillin-resistant Staphylococcus aureus. Clinical Infectious Disease 2009; 48: 910–913.
6.Cooper BS, et al. Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes. Proceedings of the National Academy of Sciences USA 2004; 101: 10223–10228.
7.MacKinnon MM, Allen KD. Long-term MRSA carriage in hospital patients. Journal of Hospital Infection 2000; 46: 216–221.
8.Robotham JV, et al. Meticillin-resistant Staphylococcus aureus (MRSA) in hospitals and the community: model predictions based on the UK situation. Journal of Hospital Infection 2007; 65 (Suppl. 2): 93–99.
9.Evans RS, et al. System-wide surveillance for clinical encounters by patients previously identified with MRSA and VRE. Studies in Health Technology and Informatics 2004; 107: 212–216.
10.Gransden WR, et al. Computerized detection of re-admission of patients with MRSA. Journal of Hospital Infection 1998; 40: 159–160.
11.Pittet D, et al. Automatic alerts for methicillin-resistant Staphylococcus aureus surveillance and control: role of a hospital information system. Infection Control and Hospital Epidemiology 1996; 17: 496–502.
12.Kac G, et al. Impact of electronic alerts on isolation precautions for patients with multidrug-resistant bacteria. Archives of Internal Medicine 2007; 167: 2086–2090.
13.European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). EUCAST Definitive Document E.DEF 2.1, August 2000: Determination of antimicrobial susceptibility test breakpoints. Clinical Microbiology and Infection 2000; 6: 570–572.
14.Kaye KS, et al. The deadly toll of invasive methicillin-resistant Staphylococcus aureus infection in community hospitals. Clinical Infectious Disease 2008; 46: 1568–1577.
15.Vriens MR, et al. Methicillin-resistant Staphylococcus aureus carriage among patients after hospital discharge. Infection Control and Hospital Epidemiology 2005; 26: 629–633.